This technology is a current supply method and device for cancer treatment that supplies current to cancer cell regions using an implanted electrode, measures bioimpedance, and sets and provides electric fields for TTF.
Conventional Tumor Treating Fields (TTF) had limitations such as electrode stimulation and energy attenuation.
This technology sets the frequency, intensity, and duty cycle of the electric field based on the measured bioimpedance, thereby improving energy management efficiency and patient usability.
WO2023-063626A1